/ /

  • linkedin
  • Increase Font
  • Sharebar

    Newborn PPH from antidepressant use?


    Newborn PPH from antidepressant use?

    A cohort study in a large group of publicly insured women seems to indicate that using selective serotonin reuptake inhibitors (SSRI) late in pregnancy may increase the risk of persistent pulmonary hypertension in a newborn.

    Researcher used the Medicaid Analytic eXtract for 46 states and Washington DC from 2000 to 2010, with a last follow-up date of December 21, 2010. The pool included 3,789,330 pregnant women who were enrolled in Medicaid from 2 months or fewer after the date of their last menstrual period to at least 1 month after delivery. The source cohort included only women with a diagnosis of depression.

    A total of 128,950 (3.4%) women had filled at least 1 prescription of antidepressants late in pregnancy, 102,179 (2.7%) of whom used an SSRI and 26,771 (0.7%) of whom used a non-SSRI. Among the babies not exposed to antidepressants, 7630 were diagnosed with pulmonary hypertension (20.8 per 10,000 births; 95% confidence interval [CI], 20.4-21.3 per 10,000 births) compared with 322 infants exposed to SSRIs (31.5; 95% CI, 28.3-35.2 per 10,000 births) and 78 infants exposed to non-SSRIs (29.1; 95% CI, 23.3-36.4 per 10,000 births).


    Judith M. Orvos, ELS
    Judith M. Orvos, ELS, is a a BELS-certified medical writer and editor and an editorial consultant for Contemporary OB/GYN.
    Lisette Hilton
    Lisette Hilton is president of Words Come Alive, based in Boca Raton, Florida.


    You must be signed in to leave a comment. Registering is fast and free!

    All comments must follow the ModernMedicine Network community rules and terms of use, and will be moderated. ModernMedicine reserves the right to use the comments we receive, in whole or in part,in any medium. See also the Terms of Use, Privacy Policy and Community FAQ.

    • No comments available


    Latest Tweets Follow